Member Info for jdt1990

Less of the sweety Allah.....not my bag.
"I know you dislike my ideas for some reason" - You don't have any ideas to dislike, just a few stray posts with zero value, stick to GDR.

https://www.bbc.co.uk/news/uk-england-london-55577426

Wonder if he got bored of waiting for AS to deliver and took it upon himself to make back the shortfall?

Totally agree - its a complete mystery. CONDOR were late to the party for sure, first Mass Spec patient samples only getting done mid Nov. Maybe a shortfall of patients in summer would explain a month or two but there's no shortage now for sure.
https://twitter.com/PerditaB/status/1330155820923883521
Who knows if we will ever find out - I am a huge advocate of AS and this business but as you say, doesn't mean its perfect o flawless. It's all very cloak and dagger - is there a reason or not? Again maybe we will or wont find out...
Let's just hope quality prevails - helping your Etonian mates out when there's 100 cases a day Vs now 1000 deaths a day....its crunch time for all involved!

~3% drop in gold price today but lets not forget it was $1500/oz start of 2020, peaked just over $2000/oz settling around $1900. That's with zero economic impact from Covid coming into play, which is going to be very bleak as all they can right now is print money. Gold has a long way to go from here - especially by the time we get to mining the stuff!

That doesn't explain BAMS though oxygen which would be useful in a hospital setting. That's been with CONDOR since July and on sale via Adeptrix since Sept for research purposes....so you would have to assume BAMS works otherwise why would Adeptrix sell it?
Too busy buying cr*p LFT's from China, buying PPE from some fellas shed in Turkey and handing contracts to other Etonian pplebs

TBF Ghana have 5 bank holidays over Xmas/NY period so I imagine very little gets done in Dec. Last one of those was yesterday so January could be the month...I hope....

Allah - thanks for the insight think I'll steer clear of your ideas, if I am not mistaken you think PI's are mugs because their shares bought on the SECONDARY market funded AS's house. I'd have a quick gander at investopedia or maybe this could be a good £4 to spend!
https://www.etsy.com/uk/listing/802060869/trading-for-dummies-book?

Richob - you raise a really interesting point here generally with milestone payments / royalty agreements etc. We know in some cases the up fronts, but as someone mentioned before, these tend to be "smaller" whilst our tech is still being proved up.
The royalty deals have to be kept confidential otherwise the second you announce them, that's your floor and negotiating position gone.
So.....on that basis - we wont really know what revenue is coming in the door until accounts are produced. A lot of people looking for that govt contract / tender award etc (which of course if it comes will be material). But I do think there could be a shock moment, as the licensing builds momentum, where the accounts are produced and we all go "Christ, where did that money come from"

It's a fair point pardariff. However, when the AVA600 RNS landed, on time....for me that cemented the view I (and others here) had that the delays were due to third parties and govts moving the goalposts. Some of which can be forgiven in the sense that COvid was a completely unknown entity, so it was always going to change. BUT there is no doubt incompetence and looking after mates has also been a nightmare.
The Affimers were done for the LFT's donkeys ago. AS I think knew what we had was good and was just naive to assume an end product would be so quick with all the red tape we have come to see.
We've moved on from Saliva which shows AVCT's willingness to adapt.
He also hasn't dedicated all resource to the Covid work because there are too many people out to look out for each other in this game it would seem.
He's a scientist and clearly believes there is still a market for the tests - so I trust that judgement otherwise we would have just stopped when the vaccines came out.
AS isnt a cowboy like some of the CEO's in dog shares I have invested in previously, you can see them a mile off. He'll deliver just may not be as quick as many had hoped/expected. Some are okay with that - others arent - thats life and investing !

Sorry I didn't finish that previous post. When you look at yesterdays RNS (which went way way way under the radar IMO!) It just shows why AS is protecting the reputation of what AVCT have and avoiding this incredibly shady "race for Covid cash". Quality wins out in the end.....how many of us buy a cheap knock off phone charger because Apple's are so expensive but after the 19th one blows up and sets your house on fire, you always buy the Apple one in the end!!

"Big bucks await if it can deliver in the next 10 days !" I have to disagree there pradriff and this is where I feel so many misunderstand AVACTA.
If AVCT can deliver in the next few days/weeks with a top quality test that AS is happy to put the Affimer name to and will be the new standard, then yes there are some big bucks to be made.
However, when you look at the criticism cr*p tests have come under - if we cannot deliver that quality near term, no test in the market is better than releasing an average one. The knock on implications in both the diagnostics and therapeutics space would be far bigger than the lost revenue.
AVCT is Affimers in the diagnostics space, not LFT's. Licensing deals outside of COVID are basically free money - someone pays us to use our IP that we have already done the leg work for, it's infinitely scalable.
I dont think that Astrea deal would have happened if we had put out a test like Innovas and come under so much fire....
However,

Reckoner - There are so many free platforms now where people can buy single digit or even partial shares. I wouldn't read into any more than just a bunch of people with £20 spare trying to "build a portfolio" a tenner at a time.

pardariff - I'm with Richob that I agree in the main. "for the last 6 months have not delivered a test and like it or not this has meant a large shortfall in potential income to the company"
No disputing the above. However, what I think a lot of people are missing is that the longer term business model revolves around the same IP, Affimers. Delivering a sub par test impacts that long term business plan significantly. So I am of the opinion AS sees a lot more money in the long game than the shorter term Covid opportunity. However, the fact Avct continue to work on it suggests they are keen to benefit, it just has to be with the right, best in class product.

Covid herd investors dont like that because it scuppers the 5000000% in a day gains they wanted, but that's the opportunity cost here. As a LTH, I am more than happy we haven't done an Innova and just put out an okay test to earn a few quid as the longer term impact would be way more than lost COvid revenue.

Remember, Covid is an unknown entity and could just die out tomorrow (not likely but hypothetically). Cancer is better understood and going nowhere - impacting 1 in 2 people in their lifetime! Add to that, the exact reason they want to protect the integrity of the Affimer platform, so it can be multi functional. "Affimers are for life, not just for Covid" I think AS has on his office wall.

Not as much as that DOH post scaredy - absolute gold but this also made me laugh - from the Washington Post....smooth rollout anyone?
"A handful of lucky Americans have been offered spontaneous vaccinations from pharmacists, who have to either use or throw out their doses within six hours after removing them from deep-freeze storage. Thus, more than 100 people got shots after a refrigerator failed in Ukah, Calif., and two friends browsing a D.C. supermarket around closing time were randomly invited to get inoculated months ahead of schedule."

He's a muppet!

"He thinks biotech companies will be lured here by the prospect of ‘a brilliant experience with the regulator’, which is less bureaucratic and able to move at speed."
BAMS says otherwise! Only people with that view are the mates the govt have paid for cra*py products

Agreed newtrader - they were struggling to get people signed up early doors, only had 40 signed up 19th Nov. They announced today approval to recruit patients in Romania and Czech Rep so the way this pandemic is going it could gather some pace quite quickly

https://twitter.com/st_capital/status/1347145246648492038

Totally agree. One issue I think the market has with AVCT's agreements (outside of up front payments) is the commercial sensitivity of the terms, i.e. what is that royalty $ or %. There will come a point where the accounts are published and people see material increases in the revenue numbers - they'll soon take not ethen!

Come on wyndrum basic maths and risk management - "such a great opportunity hartyh that you won't sell any of your 66% portfolio to take advantage, but if you found a few grand down the back of the sofa you would buy more AVCT (which would have the effect of increasing your % of AVCT in your portfolio). So why don't you just sell some other stocks that you own and use those funds?"

So if he sets himself a 1/3 limit on allocation to a stock and has $100 - that's $33 in that stock - selling something else to buy more takes you overweight.
If he finds some money and now has $200 - he can buy another $33 and not be overweight

Lightbulb?

Wouldn't expect anything on the COvid related front in a Precision RNS - completely different thing - therapeutics business v diagnostics. Not to mention this is a significant piece of news and deserves focus.
Sadly, as we have come to know, this company is priced predominantly on the Covid news which when you see what is going on away from that in the therapeutics space is ludicrous.
Hopefully that Covid related RNS comes soon, the rainbow chasers can sell up and we can go back to a focus on more than just a blo*dy LFT!

Agreed Sounds like there's been plenty of conversations going on with the aviation industry. More to do with the quarantine and testing of inbound passengers but the "we’ll be seeing more very shortly.” bit may answer that.
It does suggest testing is going nowhere regardless!
https://www.theguardian.com/world/2021/jan/05/overseas-visitors-face-uk-curbs-amid-fears-of-fresh-covid-variants
"The test to release scheme finally got under way in mid-December, but was immediately thrown into chaos when it emerged that tests were not available from most of the providers.

Speaking on Tuesday morning, Gove told Sky News: “I talked last night to the first ministers of Scotland, Wales and Northern Ireland because we want to operate on a UK-wide basis. And we’ll be coming forward very shortly with new proposals on how exactly we will make sure that our borders are safe.

“But the message is very, very clear for UK citizens that they should not be travelling. Of course, there is a natural concern about people coming into this country and, as I say, we’ll be seeing more very shortly.”

According to the Times, senior aviation sources have said the government had planned to “revisit” the rules but that recent events, including the new South African variant, had prompted “a hastening in the introduction of measures”.